Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: December 06, 2021
Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: October 16, 2019
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3).
Journal: Diabetes, obesity & metabolism
Published: March 18, 2019
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naïve cohort study.
Journal: Diabetes, obesity & metabolism
Published: December 06, 2018
Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes.
Journal: BMJ open diabetes research & care
Published: August 02, 2018
Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL.
Journal: Endocrinology, diabetes & metabolism
Published: March 14, 2018
Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.
Journal: Diabetes, obesity & metabolism
Published: August 15, 2017
Showing 1-7 of 7
Last Updated: 09/26/2026